These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 28098793)
1. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. Bondar C; Ormazabal M; Crivaro A; Ferreyra-Compagnucci M; Delpino MV; Rozenfeld PA; Mucci JM Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098793 [TBL] [Abstract][Full Text] [Related]
2. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease. Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352 [TBL] [Abstract][Full Text] [Related]
3. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging. Davis HM; Pacheco-Costa R; Atkinson EG; Brun LR; Gortazar AR; Harris J; Hiasa M; Bolarinwa SA; Yoneda T; Ivan M; Bruzzaniti A; Bellido T; Plotkin LI Aging Cell; 2017 Jun; 16(3):551-563. PubMed ID: 28317237 [TBL] [Abstract][Full Text] [Related]
4. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow microenvironment in an in vitro model of Gaucher disease: consequences of glucocerebrosidase deficiency. Lecourt S; Vanneaux V; Cras A; Freida D; Heraoui D; Herbi L; Caillaud C; Chomienne C; Marolleau JP; Belmatoug N; Larghero J Stem Cells Dev; 2012 Jan; 21(2):239-48. PubMed ID: 21867425 [TBL] [Abstract][Full Text] [Related]
7. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro. Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951 [TBL] [Abstract][Full Text] [Related]
8. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro. Wu Q; Zhou X; Huang D; Ji Y; Kang F Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513 [TBL] [Abstract][Full Text] [Related]
9. Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology. Mucci JM; Cuello MF; Kisinovsky I; Larroude M; Delpino MV; Rozenfeld PA Blood Cells Mol Dis; 2015 Aug; 55(2):134-43. PubMed ID: 26142329 [TBL] [Abstract][Full Text] [Related]
10. Effect of fluoride on osteocyte-driven osteoclastic differentiation. Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525 [TBL] [Abstract][Full Text] [Related]
11. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro. Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449 [TBL] [Abstract][Full Text] [Related]
12. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss. Shandala T; Shen Ng Y; Hopwood B; Yip YC; Foster BK; Xian CJ J Cell Physiol; 2012 Jul; 227(7):2889-97. PubMed ID: 21938727 [TBL] [Abstract][Full Text] [Related]
13. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635 [TBL] [Abstract][Full Text] [Related]
14. Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α. Mucci JM; Scian R; De Francesco PN; García FS; Ceci R; Fossati CA; Delpino MV; Rozenfeld PA Gene; 2012 Nov; 509(1):51-9. PubMed ID: 23010424 [TBL] [Abstract][Full Text] [Related]
15. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296 [TBL] [Abstract][Full Text] [Related]
16. Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro. He F; Bai J; Wang J; Zhai J; Tong L; Zhu G J Cell Physiol; 2019 Aug; 234(10):17314-17325. PubMed ID: 30786022 [TBL] [Abstract][Full Text] [Related]
17. RANKL subcellular trafficking and regulatory mechanisms in osteocytes. Honma M; Ikebuchi Y; Kariya Y; Hayashi M; Hayashi N; Aoki S; Suzuki H J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793 [TBL] [Abstract][Full Text] [Related]
18. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. Li B; Lu D; Chen Y; Zhao M; Zuo L Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110777 [TBL] [Abstract][Full Text] [Related]